Alpha Tau Medical Ltd., (DRTS): Price and Financial Metrics
DRTS Price/Volume Stats
| Current price | $3.03 | 52-week high | $4.39 |
| Prev. close | $3.07 | 52-week low | $1.75 |
| Day low | $3.02 | Volume | 1,609 |
| Day high | $3.07 | Avg. volume | 69,443 |
| 50-day MA | $2.79 | Dividend yield | N/A |
| 200-day MA | $2.76 | Market Cap | 213.25M |
DRTS Stock Price Chart Interactive Chart >
Alpha Tau Medical Ltd., (DRTS) Company Bio
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
DRTS Price Returns
| 1-mo | 7.07% |
| 3-mo | 14.34% |
| 6-mo | -1.30% |
| 1-year | 28.94% |
| 3-year | -66.22% |
| 5-year | N/A |
| YTD | -2.26% |
| 2024 | 2.99% |
| 2023 | -5.35% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...